June 25, 2003 (New Orleans) — Cardiology appears poised to follow oncology into the future with the development of machines that fuse positron emission tomography (PET) and computed tomography (CT) ...

Prostate-specific membrane antigen (PSMA)-PET/CT imaging identified metastatic prostate cancer in almost half of high-risk cases missed by conventional imaging, a retrospective analysis showed.

In elderly patients with suspected prostate cancer, PSMA PET/CT can diagnose advanced disease and aid in therapy selection without the need for a biopsy. Published in the July issue of The Journal of ...

PET-CT is a modern functional imaging modality which is obtained by a combination of PET (Positron emission tomography) and CT (computerised tomography) in a single examination. This combination ...

Predictors of PSMA positivity at initial staging of prostate cancer. Pre-surgical 68Ga-PSMA-11 PET for biochemical recurrence risk assessment: A surrogate of pelvic lymph node dissection? Follow-up ...

Baseline cell-free DNA (cfDNA) and metabolic tumor volume (MTV) independently predict outcome in metastatic chemorefractory colorectal cancer (mCRC). This is an ASCO Meeting Abstract from the 2017 ...

Advances in Total-Body PET/CT Research. Journal of Biosciences and Medicines, 14, 274-282. doi: 10.4236/jbm.2026.141021 . PET ...

The Foresight CLARITY test offers greater prognostic accuracy than PET/CT scans in large B-cell lymphoma by detecting ctDNA-MRD negativity, indicating better patient outcomes. ctDNA-MRD testing showed ...

Carly Bartuccio talks with event attendees about the new PET-CT scanner at a ribbon-cutting. Nothing can replace the caring touch of a health care worker, nor the expert clinical decision-making of a ...

A novel AI approach can accurately detect six different types of cancer on whole-body PET/CT scans, according to research presented at the 2024 Society of Nuclear Medicine and Molecular Imaging Annual ...